Bleeding Edge

The Bleeding Edge is the only free newsletter that features investing insights from editor Colin Tedards. Here, Colin will share what he's watching in the market and which stocks you'll want on your radar.

What I Discovered in America’s Heartland…

In lieu of our daily dispatch, I thought I’d do something a bit different today. I want to share some of the insights I gleaned during a recent cross-country trip… and how they lead me to a huge breakthrough regarding the future of America’s 5G rollout.

Should We Invest in the COVID-19 Stock Surge?

With all the positive news from Moderna and Pfizer regarding their respective COVID-19 vaccines, it’s natural for investors to wonder whether these companies would be good options for their portfolios. And there’s one key metric we can use to determine how to invest in the biotech sector’s gains: valuation.